Simmons Bank’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $9.47M | Buy |
26,161
+1,336
| +5% | +$457K | 0.54% | 47 |
|
|
2026
Q1 | $8.73M | Buy |
24,825
+717
| +3% | +$256K | 0.59% | 41 |
|
|
2025
Q4 | $7.89M | Buy |
24,108
+1,602
| +7% | +$508K | 0.53% | 47 |
|
|
2025
Q3 | $6.35M | Sell |
22,506
-219
| -1% | -$63.5K | 0.42% | 54 |
|
|
2025
Q2 | $6.35M | Buy |
22,725
+182
| +0.8% | +$51.6K | 0.45% | 52 |
|
|
2025
Q1 | $7.02M | Sell |
22,543
-417
| -2% | -$123K | 0.53% | 47 |
|
|
2024
Q4 | $5.98M | Sell |
22,960
-121
| -0.5% | -$35.9K | 0.44% | 58 |
|
|
2024
Q3 | $7.44M | Buy |
23,081
+194
| +0.8% | +$63.5K | 0.54% | 51 |
|
|
2024
Q2 | $7.15M | Sell |
22,887
-705
| -3% | -$207K | 0.54% | 49 |
|
|
2024
Q1 | $6.71M | Buy |
23,592
+708
| +3% | +$207K | 0.5% | 49 |
|
|
2023
Q4 | $6.59M | Sell |
22,884
-4,360
| -16% | -$1.19M | 0.54% | 46 |
|
|
2023
Q3 | $7.32M | Buy |
27,244
+736
| +3% | +$184K | 0.65% | 42 |
|
|
2023
Q2 | $5.89M | Sell |
26,508
-623
| -2% | -$145K | 0.49% | 57 |
|
|
2023
Q1 | $6.56M | Buy |
27,131
+1,500
| +6% | +$368K | 0.56% | 43 |
|
|
2022
Q4 | $6.73M | Buy |
25,631
+1,028
| +4% | +$276K | 0.58% | 44 |
|
|
2022
Q3 | $5.54M | Buy |
24,603
+1,190
| +5% | +$288K | 0.52% | 49 |
|
|
2022
Q2 | $5.7M | Buy |
23,413
+1,475
| +7% | +$361K | 0.5% | 50 |
|
|
2022
Q1 | $5.3M | Buy |
21,938
+1,302
| +6% | +$299K | 0.4% | 67 |
|
|
2021
Q4 | $4.64M | Buy |
20,636
+581
| +3% | +$123K | 0.33% | 78 |
|
|
2021
Q3 | $4.26M | Sell |
20,055
-115
| -0.6% | -$26.5K | 0.31% | 79 |
|
|
2021
Q2 | $4.92M | Buy |
20,170
+2,681
| +15% | +$660K | 0.36% | 75 |
|
|
2021
Q1 | $4.35M | Buy |
17,489
+1,946
| +13% | +$464K | 0.33% | 75 |
|
|
2020
Q4 | $3.57M | Buy |
15,543
+2,746
| +21% | +$633K | 0.28% | 85 |
|
|
2020
Q3 | $3.25M | Sell |
12,797
-41
| -0.3% | -$10.2K | 0.27% | 87 |
|
|
2020
Q2 | $3.03M | Buy |
12,838
+717
| +6% | +$164K | 0.25% | 93 |
|
|
2020
Q1 | $2.46M | Buy |
12,121
+2,011
| +20% | +$439K | 0.21% | 89 |
|
|
2019
Q4 | $2.44M | Sell |
10,110
-275
| -3% | -$60.6K | 0.22% | 103 |
|
|
2019
Q3 | $2.01M | Sell |
10,385
-347
| -3% | -$66.6K | 0.2% | 113 |
|
|
2019
Q2 | $1.98M | Buy |
10,732
+96
| +0.9% | +$17.2K | 0.19% | 114 |
|
|
2019
Q1 | $2.02M | Sell |
10,636
-70
| -0.7% | -$13.4K | 0.2% | 114 |
|
|
2018
Q4 | $2.08M | Buy |
10,706
+25
| +0.2% | +$4.88K | 0.23% | 94 |
|
|
2018
Q3 | $2.21M | Sell |
10,681
-179
| -2% | -$35.3K | 0.22% | 102 |
|
|
2018
Q2 | $2M | Buy |
10,860
+245
| +2% | +$43.3K | 0.18% | 113 |
|
|
2018
Q1 | $1.81M | Sell |
10,615
-66
| -0.6% | -$12.1K | 0.16% | 114 |
|
|
2017
Q4 | $1.86M | Buy |
10,681
+27
| +0.3% | +$4.78K | 0.19% | 108 |
|
|
2017
Q3 | $1.99M | Buy |
10,654
+1,305
| +14% | +$231K | 0.21% | 108 |
|
|
2017
Q2 | $1.61M | Sell |
9,349
-145
| -2% | -$23.6K | 0.18% | 110 |
|
|
2017
Q1 | $1.56M | Buy |
9,494
+26
| +0.3% | +$4.32K | 0.17% | 109 |
|
|
2016
Q4 | $1.38M | Buy |
9,468
+126
| +1% | +$19K | 0.16% | 126 |
|
|
2016
Q3 | $1.56M | Sell |
9,342
-152
| -2% | -$25.7K | 0.17% | 113 |
|
|
2016
Q2 | $1.45M | Sell |
9,494
-130
| -1% | -$20.2K | 0.16% | 120 |
|
|
2016
Q1 | $1.44M | Buy |
+9,624
| New | +$1.43M | 0.16% | 126 |
|
Other funds holding AMGN
Simmons Bank's AMGN Position: Q2 2026 in Review
Simmons Bank increased its Amgen (AMGN) stake by 5.4% in Q2 2026, buying an estimated $457K and bringing the position to 26,161 shares worth $9.47M. The position accounts for 0.54% of the portfolio, ranked #47.
Simmons Bank first reported a position in AMGN in Q1 2016 and has held it in 42 quarters since. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Simmons Bank held 26,161 shares of Amgen worth $9.47M as of Q2 2026.
- Simmons Bank bought 1,336 Amgen shares in Q2 2026, an estimated $457K.
- Amgen made up 0.54% of Simmons Bank's portfolio in Q2 2026, its #47 holding.
- Simmons Bank first reported a position in Amgen in Q1 2016 and has held it in 42 quarters since.
- 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Simmons Bank's 13F filing for Q2 2026, filed 31 Jul 2026.